LEVOPROME Drug Patent Profile
✉ Email this page to a colleague
When do Levoprome patents expire, and what generic alternatives are available?
Levoprome is a drug marketed by Immunex and is included in one NDA.
The generic ingredient in LEVOPROME is levomepromazine. There are two drug master file entries for this compound. Additional details are available on the levomepromazine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEVOPROME?
- What are the global sales for LEVOPROME?
- What is Average Wholesale Price for LEVOPROME?
Summary for LEVOPROME
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Patent Applications: | 3,676 |
| DailyMed Link: | LEVOPROME at DailyMed |
US Patents and Regulatory Information for LEVOPROME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunex | LEVOPROME | levomepromazine | INJECTABLE;INJECTION | 015865-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
